BONANNI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.706
EU - Europa 22.854
AS - Asia 12.448
SA - Sud America 1.884
Continente sconosciuto - Info sul continente non disponibili 441
AF - Africa 384
OC - Oceania 270
Totale 64.987
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.107
IT - Italia 5.914
RU - Federazione Russa 5.864
PL - Polonia 5.316
SG - Singapore 3.445
CN - Cina 2.683
HK - Hong Kong 1.896
BR - Brasile 1.455
VN - Vietnam 1.397
IE - Irlanda 1.328
SE - Svezia 1.134
KR - Corea 1.061
FR - Francia 667
FI - Finlandia 664
DE - Germania 610
IN - India 473
GB - Regno Unito 395
CA - Canada 346
UA - Ucraina 259
AU - Australia 258
BD - Bangladesh 257
JO - Giordania 230
TR - Turchia 203
ID - Indonesia 194
CH - Svizzera 181
NL - Olanda 177
JP - Giappone 168
AR - Argentina 155
ES - Italia 110
CI - Costa d'Avorio 82
MX - Messico 82
ZA - Sudafrica 76
EC - Ecuador 73
IQ - Iraq 67
CO - Colombia 60
PK - Pakistan 52
PH - Filippine 51
NG - Nigeria 48
EG - Egitto 34
PE - Perù 34
VE - Venezuela 34
MY - Malesia 32
MA - Marocco 31
PY - Paraguay 30
BE - Belgio 28
CZ - Repubblica Ceca 28
JM - Giamaica 28
UZ - Uzbekistan 27
SA - Arabia Saudita 26
AE - Emirati Arabi Uniti 25
CR - Costa Rica 24
CL - Cile 23
BG - Bulgaria 20
LT - Lituania 20
TH - Thailandia 20
TN - Tunisia 19
HN - Honduras 18
KE - Kenya 18
AT - Austria 17
TT - Trinidad e Tobago 17
AL - Albania 16
SC - Seychelles 16
GT - Guatemala 15
BH - Bahrain 14
DO - Repubblica Dominicana 14
DZ - Algeria 14
RO - Romania 14
PT - Portogallo 13
GE - Georgia 12
IL - Israele 12
KZ - Kazakistan 12
UY - Uruguay 11
AZ - Azerbaigian 10
BB - Barbados 10
LV - Lettonia 10
OM - Oman 10
SV - El Salvador 10
TW - Taiwan 10
NO - Norvegia 9
NP - Nepal 9
PR - Porto Rico 9
EE - Estonia 8
IR - Iran 8
NZ - Nuova Zelanda 8
BO - Bolivia 7
GR - Grecia 7
KG - Kirghizistan 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
BJ - Benin 6
ET - Etiopia 6
HR - Croazia 6
MQ - Martinica 6
QA - Qatar 6
LU - Lussemburgo 5
MD - Moldavia 5
NI - Nicaragua 5
PA - Panama 5
SI - Slovenia 5
AM - Armenia 4
Totale 64.458
Salva come PNG Salva come JPEG
Città #
Warsaw 5.293
Santa Clara 5.169
Ashburn 2.975
Singapore 2.467
Fairfield 1.609
Hong Kong 1.560
San Jose 1.417
Dublin 1.319
Chandler 1.097
Seoul 1.042
Milan 939
Seattle 700
Woodbridge 674
Council Bluffs 651
Cambridge 628
Beijing 595
Houston 579
Florence 558
Wilmington 548
Rome 520
Hefei 487
Los Angeles 451
Ho Chi Minh City 433
Buffalo 413
Princeton 393
Jacksonville 366
Lauterbourg 360
Lawrence 352
The Dalles 333
Altamura 322
Boston 314
Hanoi 313
Moscow 312
New York 308
Helsinki 280
Mumbai 278
Ann Arbor 256
Boardman 221
Melbourne 208
Chicago 193
Phoenix 170
Munich 163
Naples 160
Tokyo 160
Dallas 156
Bern 155
Jakarta 144
Medford 140
Shanghai 133
San Diego 131
Kent 130
Bologna 120
São Paulo 117
Paris 108
Turin 103
Izmir 101
Clifton 96
Toronto 91
Dong Ket 85
Turku 85
Abidjan 82
Montreal 82
London 78
Genoa 76
Frankfurt am Main 75
Orem 71
Palermo 70
Redondo Beach 70
Bari 65
Norwalk 65
Atlanta 61
Rio de Janeiro 61
Da Nang 58
Brooklyn 57
Lappeenranta 57
Barcelona 56
Figino 56
Dearborn 46
Haiphong 45
Bremen 41
Falls Church 41
Hillsboro 40
Philadelphia 40
Abuja 39
Chennai 39
Denver 36
Guangzhou 36
Verona 36
Washington 36
Catania 35
San Francisco 35
Tianjin 33
Venice 33
Amsterdam 32
Andover 31
Miami 31
Falkenstein 30
Lima 30
Miano 29
Brasília 28
Totale 41.443
Salva come PNG Salva come JPEG
Nome #
Manuale di igiene e sanità pubblica 717
Vaccinazioni e asplenia: quale percorso per il paziente splenectomizzato? 645
HPV vaccination for boys? A systematic review of economic studies 463
Antimeningococcal and antipneumococcal vaccination determinants: A European systematic literature review 437
Beliefs and Opinions of Health Care Workers and Students Regarding Influenza and Influenza Vaccination in Tuscany, Central Italy 355
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy 348
A summer school on vaccinology: Responding to identified gaps in pre-service immunisation training of future health care workers. 342
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis 335
Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants’ vaccination? 331
Predictive factors associated with the acceptance of pandemic and seasonal influenza vaccination in health care workers and students in Tuscany, Central Italy 327
Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines 322
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 319
Primary hepatitis A vaccination failure is a rare although possible event: results of a retrospective study 318
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis 313
Preventing and managing herpes zoster: key actions to foster healthy aging 311
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015 310
Budget impact analysis of universal rotavirus vaccination in the Local Health Unit 11 Empoli, Tuscany, Italy 309
Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: Where is the greatest benefit for cervical cancer prevention in Italy? 309
Monitoring the web to support vaccine coverage: Results of two years of the portal VaccinarSì 307
[The 2014 lifetime immunization schedule approved by the Italian scientific societies. Italian Society of Hygiene, Preventive Medicine, and Public Health. Italian Society of Pediatrics. Italian Federation of Pediatric Physicians. Italian Federation of General Medical Physicians. Arezzo Service of Legal Medicine] 305
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention 305
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 304
Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004-2012 304
Coverage or Efficacy: Which Factor is the Most Influential for Reducing Varicella with Routine Childhood Vaccination in Italy? 302
Human papilloma virus vaccination: impact and recommendations across the world. 300
Incidence of infection-associated cancers in Italy and prevention strategies 293
How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome chapter project 288
Detection and genotyping of human papillomavirus in urine samples from unvaccinated male and female adolescents in Italy. 283
Varicella vaccination in Europe – taking the practical approach 282
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment 282
Non-familial paid caregivers as potential flu carriers and cause of spread: the primary prevention of flu measured through their adhesion to flu vaccination campaigns—A Florentine experience 282
A new meningococcal B vaccine for adolescents and adults: characteristics and methods of use 275
Raccomandazioni ed evidenze scientifiche a supporto del valore della vaccinazione DTPa-IPV in età prescolare 274
The epidemiology of mumps in Italy 274
The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries. 270
Lifelong vaccination as a key disease-prevention strategy 267
The epidemiology of Varicella Zoster Virus infection in Italy. 262
Safety and perception: What are the greatest enemies of HPV vaccination programmes? 260
New Italian immunisation plan is built on scientific evidence: Carlo Signorelli and colleagues reply to news article by Michael Day 258
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 252
Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy 252
Fake news and covid-19 in Italy: Results of a quantitative observational study 251
Vaccines Safety in Children and in General Population: A Pharmacovigilance Study on Adverse Events Following Anti-Infective Vaccination in Italy 247
L’EFFICACIA DEL PROGRAMMA DI VACCINAZIONE UNIVERSALE ANTI-VARICELLA IN TOSCANA: EVIDENZE DI UN OBIETTIVO RAGGIUNGIBILE DEL PNPV. 246
Human Papilloma Virus Vaccination and Cervical Screening in the Italian Regions: An Overview of the Current State of the Art 245
Erratum: Corrigendum to “Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines” (Vaccine (2016) 34(6) (757–761) (S0264410X15018745) (10.1016/j.vaccine.2015.12.063)) 245
Attitudes and perceptions of Italian Students in Healthcare Settings on COVID-19 vaccines and vaccinations strategies, one year after the immunization campaign 240
Electronic Package Leaflets for Vaccines: What Are People's Perceptions in Italy? 236
Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign? 230
Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions 229
The "Fluad Case" in Italy: Could it have been dealt differently? 229
Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy 229
Vaccination as a social practice: towards a definition of personal, community, population, and organizational vaccine literacy 228
Childhood Vaccination Coverage in Europe: Impact of different Public Health Policies 227
Economic burden of HPV9-related diseases: a real-world cost analysis from Italy 226
The burden of hospitalization due to HPV infections in Tuscany, Central Italy 223
Progress in Italy in control and elimination of measles and congenital rubella. 215
Recommended vaccinations for asplenic and hyposplenic adult patients 212
Recrudescenza di casi di malattia meningococcica invasiva in Toscana e strategie vaccinali adottate dal 2015 212
Assessing vaccine hesitancy among healthcare workers: A cross-sectional study at an Italian paediatric hospital and the development of a healthcare worker’s vaccination compliance index 212
Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades 208
The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting 207
Measles outbreak in Grosseto, central Italy, 2006. 204
[Flu vaccination and value-based health care: operational solutions to safeguard public health] 202
Rubella seroprevalence boost in the pediatric and adolescent population of florence (Italy) as a preventive strategy for congenital rubella syndrome (CRS) 202
Knowledge of University Students in Health Care Settings on Vaccines and Vaccinations Strategies: Impact Evaluation of a Specific Educational Training Course during the COVID-19 Pandemic Period in Italy 200
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) 200
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy 199
Knowledge and training of Italian students in Healthcare Settings on COVID-19 vaccines and vaccination strategies, one year after the immunization campaign 197
Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review 196
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 192
Le vaccinazioni 192
SORVEGLIANZA DEGLI EVENTI AVVERSI AI VACCINI SEGNALATI IN TOSCANA NEL 2015 192
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 191
Vaccine safety evaluation: Practical aspects in assessing benefits and risks 191
Attitudes and Perceptions of University Students in Healthcare Settings towards Vaccines and Vaccinations Strategies during the COVID-19 Pandemic Period in Italy 190
Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women. 190
Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. 188
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations 188
Analisi delle reazioni avverse alla prima dose di vaccini antimorbillo e antivaricella in Toscana dal 2011-2014. 187
An overview on the implementation of HPV vaccination in Europe. 187
Eliminazione del morbillo: risultati e prospettive nella Regione Toscana 186
Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. 184
Is hepatitis B vaccination performed at infant and adolescent age able to provide long-term immunological memory? An observational study on healthcare students and workers in Florence, Italy 183
Influenza vaccination 2014-2015: Results of a survey conducted among general practitioners in Italy. 183
Reasons for the Intention to Refuse COVID-19 Vaccination and Their Association with Preferred Sources of Information in a Nationwide, Population-Based Sample in Italy, before COVID-19 Vaccines Roll Out 182
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy. 181
Key points for the decision maker 181
Adiuvanti e vaccini coniugati 179
The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment 179
Hepatitis B seroprevalence in the pediatric and adolescent population of florence (Italy): An update 27 years after the implementation of universal vaccination 178
Seroprevalence Assessment of Anti-Varicella Antibodies among Adults in the Province of Florence (Italy) 177
The experience of vaccinarsintoscana website and the role of new media in promoting vaccination 176
Progress in Italy in control and elimination of measles and congenital rubella. 176
Analisi costo-efficacia della vaccinazione anti-meningococcica con vaccino coniugato quadrivalente ACYW135 in Italia. 176
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm? 175
Valutazione del rischio di morbillo, rosolia e parotite negli operatori sanitari dell’azienda sanitaria di Firenze (ASF) 175
COVID-19 in Italy: Considerations on official data 175
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy 175
Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project 174
Totale 25.172
Salva come PNG Salva come JPEG
Categoria #
all - tutte 182.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.742 0 0 0 86 54 69 66 214 73 101 355 724
2022/20235.953 583 942 294 367 390 1.090 784 337 705 49 197 215
2023/20242.730 123 261 443 195 167 293 158 367 109 237 213 164
2024/202516.865 615 1.820 1.145 2.426 4.526 2.153 391 949 891 539 640 770
2025/202620.391 2.094 2.524 1.648 1.715 1.934 729 2.434 923 1.470 1.387 737 2.796
2026/20273.739 867 725 1.924 223 0 0 0 0 0 0 0 0
Totale 64.987